CARDIOME PHARMA CORP's ticker is CRME and the CUSIP is 14159U301. A total of 32 filers reported holding CARDIOME PHARMA CORP in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $7,520,000 | +51.8% | 3,241,550 | +1.4% | 4.03% | +35.7% |
| Q4 2017 | $4,953,000 | -18.9% | 3,195,692 | +11.5% | 2.97% | -17.5% |
| Q3 2017 | $6,106,000 | -15.3% | 2,866,785 | +79.7% | 3.60% | -7.6% |
| Q2 2017 | $7,212,000 | -13.1% | 1,595,549 | -42.1% | 3.89% | -16.7% |
| Q1 2017 | $8,299,000 | -4.8% | 2,757,260 | -12.7% | 4.68% | -9.9% |
| Q4 2016 | $8,718,000 | +45.2% | 3,158,816 | +64.6% | 5.19% | +6.0% |
| Q3 2016 | $6,006,000 | – | 1,918,722 | – | 4.90% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alistair Capital Management, L.L.C. | 917,400 | $5,715,000 | 2.56% |
| Fortress Investment Group LLC | 2,481,596 | $15,460,000 | 0.24% |
| PERKINS CAPITAL MANAGEMENT INC | 14,000 | $87,000 | 0.06% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1,332,260 | $8,386,000 | 0.02% |
| TFS CAPITAL LLC | 26,116 | $163,000 | 0.01% |
| GROUP ONE TRADING, L.P. | 54,815 | $342,000 | 0.01% |
| Renaissance Technologies | 218,913 | $1,364,000 | 0.00% |
| Alberta Investment Management Corp | 19,140 | $128,000 | 0.00% |
| OAK RIDGE INVESTMENTS LLC | 11,055 | $69,000 | 0.00% |
| SUMMIT SECURITIES GROUP LLC | 600 | $4,000 | 0.00% |